TELA Bio, Inc. rose 17.8% on Wednesday, November 11, 2026, on 773,400 shares, 3.4 times its average daily volume. Headlines around the move:
TELA Bio, Inc. (TELA:NASDAQ) closed at $0.820 on November 13, 2026, down 4.64% on the day. The stock trades 45.3% below its 52-week high of $1.50 and 63.7% above its 52-week low of $0.501. Over the past year, it lost 17.9%. TELA Bio, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, TELA closed higher on 116 days (46%). Its best day was August 4, 2026 (+22.57%) and its worst was March 30, 2026 (-15.67%). The stock moved 10% or more in a single session 23 times.
TELA Bio Inc is a United States-based medical technology company. It is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery.
Find more stocks like TELA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.